In addition to our NIH-funded research, the Warren Lab offers contract preclinical testing services for pharmaceutical and biotech companies seeking rigorous drug self-administration data in rodent models.
Full IV drug self-administration studies in rats and mice, including acquisition, dose-response, progressive ratio, extinction, and reinstatement paradigms. We work with a wide range of compound classes and schedules of reinforcement.
Comprehensive preclinical evaluation of abuse potential for novel compounds. Our studies meet the rigor expected for IND-enabling packages and regulatory submissions.
Conditioned place preference, locomotor sensitization, and oral self-administration paradigms to characterize reward and aversion profiles of test compounds.
We collaborate closely with sponsors to design tailored protocols addressing specific preclinical questions. Flexible timelines, blinded analysis, and GLP-adjacent documentation available.